
POINT Biopharma Global Inc.
PNTNASDAQHealthcare
$12.50
+$0.02(+0.16%)
Market Cap$1.3B
P/E Ratio—
52W High$14.35
52W Low$6.57
POINT Biopharma Global Inc. (PNT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PNT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.23B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.23B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | 100.00% | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.08B | $0.03B | $0.01B | $0.00B |
| G&A Expenses | $0.02B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.10B | $0.05B | $0.01B | $0.00B |
| Operating Income | $0.13B | ($0.05B) | ($0.01B) | ($0.00B) |
| Operating Margin %(computed) | 55.40% | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.13B | ($0.05B) | ($0.01B) | ($0.00B) |
| Income Tax Expense | $0.03B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.10B | ($0.05B) | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | 43.38% | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $1.04 | $-0.62 | $-0.34 | $0.00 |
| Wtd Avg Shares | 0.09B | 0.07B | 0.04B | 0.00B |
| EBITDA | $0.13B | ($0.05B) | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | 56.19% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more POINT Biopharma Global Inc. data
About POINT Biopharma Global Inc. (PNT) Income Statement
POINT Biopharma Global Inc. (PNT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, PNT reported revenue of $0.23B, gross profit of $0.23B (gross margin 100.00%), and net income of $0.10B — a net profit margin of 43.38%.
Frequently asked questions
PNT · 4 questionsPOINT Biopharma Global Inc. (PNT) reported revenue of $0.23B for 2022, up —% year-over-year.
PNT revenuePNT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09